Naoki Mori

10PUBLICATIONS
0CO-AUTHORS
Haematological tumoursMolecular targetsMedical parasitologyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 23, 2026
Role of Nek2 and Hec1 in HTLV-1-Infected T-Cell Lines.

Chie Ishikawa, Naoki Mori

|Sep 06, 2024
A New Strategy for Adult T-Cell Leukemia Treatment Targeting Glycogen Synthase Kinase-3β.

Chie Ishikawa, Naoki Mori

|Apr 01, 2024
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult T-cell leukemia.

Chie Ishikawa, Naoki Mori

|May 10, 2023
Heat shock factor 1 is a promising therapeutic target against adult T-cell leukemia.

Chie Ishikawa, Naoki Mori

|Oct 26, 2021
FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells.

Chie Ishikawa, Naoki Mori

|Sep 22, 2020
Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy.

Chie Ishikawa, Masachika Senba, Naoki Mori

Pageof 2

Frequent Collaborators